Results 241 to 250 of about 58,672 (263)
Some of the next articles are maybe not open access.
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Arthritic diseases: melanocortin type 3 receptor agonists as potential therapeutics.
Current opinion in investigational drugs (London, England : 2000), 2002Gouty arthritis is currently treated with drugs that have an array of side effects. Therefore, identification of novel endogenous targets for drug development may have beneficial properties ACTH4-10, a heptapeptide fragment derived from the hormone adrenocorticotrophin (ACTH) modulates the inflammatory response in a corticosterone-independent manner ...
S J, Getting, M, Perretti
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Regulation of Energy Rheostasis by the Melanocortin-3 Receptor
The regulation of energy homeostasis is complex, however key physiological systems have been identified. The melanocortin system has been demonstrated to be a master regulator of energy homeostasis. Within the melanocortin system are the melanocortin-3 or -4 receptors (MC3R & MC4R).openaire +2 more sources
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
Breast cancer statistics, 2019
Ca-A Cancer Journal for Clinicians, 2019Carol E Desantis, Jiemin, Mia M Gaudet
exaly
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
Ca-A Cancer Journal for Clinicians, 2020Grace M Choong +2 more
exaly
Breast cancer statistics, 2017, racial disparity in mortality by state
Ca-A Cancer Journal for Clinicians, 2017Carol E Desantis +2 more
exaly